Clearmind Medicine Financials - Benzinga

Clearmind Medicine Inc

CMNDNASDAQ

Trade with Public

Trade with Public

$0.8580

0.05216.46%

At close: Sep 16, 5:00 PM EST

$0.8693

0.06347.87%

Pre-Market: 4:19 AM EST

Overview News Earnings Forecast EventsFinancialsSentiment Ownership Compare Stock Report

Clearmind Medicine Financials

Clearmind Medicine (CMND) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Nasdaq Down Over 150 Points; Disney Shares Fall After Q4 Results

Avi Kapoor

Nasdaq Edges Lower; Morgan Stanley Earnings Top Views

Avi Kapoor

Crude Oil Down 1%; Bank of America Posts Upbeat Earnings

Avi Kapoor

Dow Jumps 400 Points; US Retail Sales Flat For June

Avi Kapoor

PRO
Clearmind Medicine CEO Issues Letter To Shareholders; Says Poised To Achieve Significant Milestones That It Hopes To Substantially Enhance Shareholder Value Through 2024

Benzinga Newsdesk

Crude Oil Moves Higher; Clearmind Medicine Shares Plummet

U.S. stocks traded slightly lower toward the end of trading, with the Dow Jones index falling around 20 points on Thursday. The Dow traded down 0.05% to 37,675 while the NASDAQ fell 0.05% to 14,962.80. The S&P 500 also fell, dropping, 0.11% to 4,778.06.

Avi Kapoor